Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 56,224 | N/A | N/A |
| Marketable Securities | 88,904 | N/A | N/A |
| Receivables | 833 | N/A | N/A |
| TOTAL | $149,602 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 10,245 | N/A | N/A |
| Intangibles | 127,804 | 0 | 0 |
| TOTAL | $138,049 | $N/A | $N/A |
| Total Assets | $287,651 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 5,168 | 0 | 0 |
| Accrued Expenses | 6,547 | N/A | N/A |
| TOTAL | $14,287 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Deferred Revenues | 2,572 | N/A | N/A |
| Other Non-Current Liabilities | 103,642 | 0 | 0 |
| TOTAL | $148,069 | $N/A | $N/A |
| Total Liabilities | $162,356 | $N/A | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 45,274 | N/A | N/A |
| Common Shares | 45 | N/A | N/A |
| Retained earnings | -246,203 | N/A | N/A |
| Other shareholders' equity | 196 | 0 | 0 |
| TOTAL | $125,295 | $N/A | $N/A |
| Total Liabilities And Equity | $287,651 | $0 | $0 |